Title Loss of Hep Par 1 immunoreactivity in the livers of patientswith carbamoyl phosphate synthetase 1 deficiency

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular defects in human carbamoy phosphate synthetase I: mutational spectrum, diagnostic and protein structure considerations

  2011cited by this paper
• Expression of hepatocyte antigen in small intestinal epithelium and adenocarcinoma.

  2009cited by this paper
• Genetic variation in the urea cycle: a model resource for investigating key candidate genes for common diseases

  2009cited by this paper
• The antigen for Hep Par 1 antibody is the urea cycle enzyme carbamoyl phosphate synthetase 1

  2008cited by this paper
• Molecular and clinical analyses of Japanese patients with carbamoylphosphate synthetase 1 (CPS1) deficiency

  2007cited by this paper
• The frequent observation of evidence for nonsense-mediated decay in RNA from patients with carbamyl phosphate synthetase I deficiency.

  2006cited by this paper
• Quality control of mRNA function.

  2001cited by this paper
• Hepatocyte paraffin 1: a monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors.

  1993cited by this paper
• Detection of carbamyl phosphate synthetase 1 deficiency using duodenal biopsy samples.

  1980cited by this paper

• No citing papers are available for this paper.